Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Hudson |
RCV000417211 | SCV000281758 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2016-05-12 | criteria provided, single submitter | research | |
Gene |
RCV000498452 | SCV000589447 | pathogenic | not provided | 2022-08-31 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28554332, 28867141, 29393965, 31883531, 27479907, 28807008, 29021403, 29222009, 28135719, 24999027, 19344873, 25560765, 28991257, 31238879, 31036916, 29738522, 32277047, 32368696, 32901917, 31785789) |
Ambry Genetics | RCV000622786 | SCV000742245 | pathogenic | Inborn genetic diseases | 2017-03-15 | criteria provided, single submitter | clinical testing | |
Laboratory of Molecular Genetics |
RCV000498452 | SCV000920567 | pathogenic | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV000850464 | SCV000992662 | likely pathogenic | Marfanoid habitus and intellectual disability | criteria provided, single submitter | research | ||
Ce |
RCV000498452 | SCV001250331 | pathogenic | not provided | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV000417211 | SCV001439317 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2020-07-22 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV001526523 | SCV001736945 | pathogenic | Global developmental delay | criteria provided, single submitter | clinical testing | ||
3billion, |
RCV000417211 | SCV002012180 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2021-10-02 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported as de novoo in a similarly affected individual (ClinVar ID: VCV000235887.20, PMID: 27479907 and 29021403, PS1, PS2 and PS4_M). The missense variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (PM1). It is not observed in the gnomAD v2.1.1 dataset (PM2). A different missense change at the same codon (p.Asn842Asp) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000522794.5, PMID: 28807008, 29021403, PM5). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.861, 3Cnet: 0.997, PP3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Genetics and Molecular Pathology, |
RCV000417211 | SCV002556994 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2021-05-12 | criteria provided, single submitter | clinical testing | The CDK13 c.2525A>G variant is classified as PATHOGENIC (PS4, PS2, PP3) The CDK13 c.2525A>G variant is a single nucleotide change in exon 6 of the CDK13 gene, which is predicted to change the amino acid asparagine at position 842 in the protein to serine. This recurrent variant has been identified in multiple individuals with global developmental delay or intellectual disability and dysmorphic features, with or without congenital heart defects, hypotonia or hearing loss (PMID:27479907, PMID:29021403, PMID:29222009) (PS4). A number of these cases have been shown to be de novo (PMID:28807008) (PS2). This variant is in dbSNP (rs878853160) but is absent from population databases (PM2). This variant has been reported in ClinVar as Pathogenic by multiple other diagnostic laboratories (Variation ID:235887), and has been reported as damaging for congenital heart disease, developmental delay and intellectual disability in HGMD (CM1610451). Computational predictions support a deleterious effect on the gene or gene product (PP3). |
MGZ Medical Genetics Center | RCV000417211 | SCV002578968 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2022-04-22 | criteria provided, single submitter | clinical testing | |
Victorian Clinical Genetics Services, |
RCV000417211 | SCV002769358 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2022-02-02 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0105 - The mechanism of disease for this gene is not clearly established. However, haploinsufficiency, dominant negative and gain of function have been suggested in the literature (PMIDs: 30904094, 29393965, 28807008) (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from asparagine to serine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants. This variant is located in the protein kinase domain (PDB), where disease-associated missense variants are clustered (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. The variant has been reported in many patients and shown to be de novo in multiple patients (ClinVar, Deciphering Developmental Disorders (DDD) Study). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
Fulgent Genetics, |
RCV000417211 | SCV002815704 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2021-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000498452 | SCV003439941 | pathogenic | not provided | 2024-11-29 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 842 of the CDK13 protein (p.Asn842Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with CDK13-related conditions (PMID: 28807008). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 235887). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt CDK13 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000417211 | SCV003835390 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2022-08-12 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000417211 | SCV000503042 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2024-02-15 | no assertion criteria provided | literature only | |
Gene |
RCV000417211 | SCV001370887 | not provided | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | no assertion provided | literature only | ||
Department of Genetics, |
RCV000417211 | SCV001442986 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2020-06-10 | no assertion criteria provided | clinical testing | |
Service de Génétique Moléculaire, |
RCV000417211 | SCV001450704 | pathogenic | Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | 2020-09-03 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000498452 | SCV001741783 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000498452 | SCV001806804 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000498452 | SCV001956718 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000498452 | SCV002036802 | pathogenic | not provided | no assertion criteria provided | clinical testing |